Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Structure-activity relationship studies leading to the identification of (2E)-3-[l-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methyl-lH-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041), a potent and selective prostanoid EP3 receptor antagonist, as a novel antiplatelet agent that does not prolong bleeding.
J Med Chem. 2010 Jan 14;53(1):18-36. doi: 10.1021/jm9005912.
J Med Chem. 2010.
PMID: 19957930
Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
Hategan G, Polozov AM, Zeller W, Cao H, Mishra RK, Kiselyov AS, Ramirez J, Halldorsdottir G, Andrésson T, Gurney ME, Singh J.
Hategan G, et al.
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6797-800. doi: 10.1016/j.bmcl.2009.09.084. Epub 2009 Sep 27.
Bioorg Med Chem Lett. 2009.
PMID: 19836233
Item in Clipboard
Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa).
Polla MO, Tottie L, Nordén C, Linschoten M, Müsil D, Trumpp-Kallmeyer S, Aukrust IR, Ringom R, Holm KH, Neset SM, Sandberg M, Thurmond J, Yu P, Hategan G, Anderson H.
Polla MO, et al. Among authors: hategan g.
Bioorg Med Chem. 2004 Mar 1;12(5):1151-75. doi: 10.1016/j.bmc.2003.12.039.
Bioorg Med Chem. 2004.
PMID: 14980627
Item in Clipboard
Cite
Cite